Keensight Capital Acquires Majority Stake in Bedfont Scientific Ltd.

Keensight Capital Invests in Bedford Consulting

May 10, 2022

IT Services

Keensight Capital has invested a significant stake in Bedford Consulting, the leading EMEA Anaplan implementation partner, alongside Bedford co-founder Neil Doyle and CEO Cathal Doyle. The growth investment will support Bedford's international expansion, deepen its market penetration across Europe, and extend its Anaplan-related service offerings.

Keensight Capital Acquires Majority Stake in BYG4lab

July 22, 2022

Software

Keensight Capital has acquired a majority stake in BYG4lab, a France-headquartered provider of data management software for medical laboratories. The PE firm will support BYG4lab's international expansion (Europe and North America), product diversification and accelerated growth both organically and via acquisitions.

Bedford Consulting Acquires Mentat Technology with Support from Keensight Capital

February 8, 2024

IT Services

Bedford Consulting has acquired Mentat Technology, a London-based Anaplan implementation partner, with support from Keensight Capital, a major shareholder in Bedford. The deal strengthens Bedford's UK market position and sector capabilities (Finance, Insurance, Manufacturing) by adding Mentat's ~15 consultants and over 100 completed Anaplan projects to Bedford's platform.

Keensight Capital Acquires Inke from Neuraxpharm

May 1, 2023

Pharmaceuticals

Keensight Capital has signed a binding agreement to acquire Inke, a Spain-based specialist developer and manufacturer of inhalation active pharmaceutical ingredients (APIs), from Neuraxpharm Group; financial terms were not disclosed and the deal is expected to close in May 2023. Neuraxpharm divested Inke to sharpen its focus on CNS therapies, while Keensight will support Inke's management team to expand its footprint, broaden its offering and grow its product portfolio.

Keensight Capital, A.P. Moller Holding and Bonit Capital Invest in Bentley Endovascular Group AB

October 27, 2023

Medical Devices

Keensight Capital, A.P. Moller Holding and Bonit Capital have taken minority positions in Stockholm-headquartered Bentley Endovascular Group AB to support the company's US market entry and IPO preparation. The founding family and management retain majority control; Bentley—best known for covered stents and endovascular devices—will use the new capital to expand geographically and reinforce its product offering.

Keensight Capital Acquires Majority Stake in Isto Biologics

September 22, 2025

Medical Devices

Keensight Capital has acquired a majority stake in Isto Biologics, a US-based regenerative MedTech company focused on orthobiologic bone graft solutions. Thompson Street Capital Partners will retain a minority stake alongside Isto's management; Keensight plans to support Isto's international expansion and pursue additional acquisitions to accelerate growth.